We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NICE

News List

Kadcyla new deal means NICE positive recommendation in draft guidance europeanpharmaceuticalreview
June 26, 2017
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.
Patients call for halt to NICE changes pharmatimes
March 29, 2017
A coalition of almost 200 patient groups representing families affected by rare and genetic conditions have called for a halt to planned changes in the way therapies are appraised for NHS...
UK NICE to deny NHS access to BMS’s blood cancer drug Opdivo pharmaceutical-technology
March 17, 2017
The UK’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance that could deny access...
FDA and NICE approve of first new hyperparathyroidism drug in 12 years pharmafile
March 09, 2017
The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the...